tiprankstipranks
Advertisement
Advertisement

IMMX Stock Latest News

Immix Biopharma Shareholders Back Board and Auditor at AGM
Company AnnouncementsImmix Biopharma Shareholders Back Board and Auditor at AGM
10d ago
8K
IMMX
Immix Biopharma price target raised to $20 from $15 at H.C. Wainwright
PremiumThe Fly
Immix Biopharma price target raised to $20 from $15 at H.C. Wainwright
18d ago
IMMX
Immix Biopharma Raises $150 Million to Advance NXC-201
PremiumCompany Announcements
Immix Biopharma Raises $150 Million to Advance NXC-201
18d ago
8K
IMMX
Immix Biopharma Reports Strong Interim NXC-201 Phase 2 Data
PremiumCompany Announcements
Immix Biopharma Reports Strong Interim NXC-201 Phase 2 Data
19d ago
8K
IMMX
Immix Biopharma’s NXC-201 reaches 95% complete response rate in AL amyloidosis
PremiumThe Fly
Immix Biopharma’s NXC-201 reaches 95% complete response rate in AL amyloidosis
19d ago
IMMX
Citizens biotechnology analyst holds analyst/industry conference call
PremiumThe FlyCitizens biotechnology analyst holds analyst/industry conference call
2M ago
AZ
GSK
Immix Biopharma Completes NEXICART-2 Enrollment for NXC-201
Premium
Company Announcements
Immix Biopharma Completes NEXICART-2 Enrollment for NXC-201
2M ago
8K
IMMX
Immix Biopharma completes NEXICART-2 enrollment, onboards CMO Richard Graydon
Premium
The Fly
Immix Biopharma completes NEXICART-2 enrollment, onboards CMO Richard Graydon
2M ago
MRK
IMMX
Immix Biopharma price target raised to $15 from $14 at Mizuho
PremiumThe Fly
Immix Biopharma price target raised to $15 from $14 at Mizuho
2M ago
IMMX
Immix Biopharma price target raised to $15 from $12 at H.C. Wainwright
PremiumThe Fly
Immix Biopharma price target raised to $15 from $12 at H.C. Wainwright
2M ago
IMMX
Immix Biopharma Amends ATM Offering to Raise Capital
PremiumCompany Announcements
Immix Biopharma Amends ATM Offering to Raise Capital
3M ago
8K
IMMX
Immix Biopharma initiated with an Overweight at Morgan Stanley
PremiumThe Fly
Immix Biopharma initiated with an Overweight at Morgan Stanley
3M ago
IMMX
Immix Biopharma initiated with an Outperform at Citizens
PremiumThe FlyImmix Biopharma initiated with an Outperform at Citizens
3M ago
IMMX
Immix Biopharma initiated with an Outperform at Mizuho
Premium
The Fly
Immix Biopharma initiated with an Outperform at Mizuho
4M ago
IMMX
Immix Biopharma receives FDA breakthrough therapy designation for NXC-201
Premium
The Fly
Immix Biopharma receives FDA breakthrough therapy designation for NXC-201
4M ago
IMMX
Immix Biopharma files $750M mixed securities shelf
PremiumThe Fly
Immix Biopharma files $750M mixed securities shelf
5M ago
IMMX
Immix Biopharma price target raised to $12 from $8 at H.C. Wainwright
PremiumThe Fly
Immix Biopharma price target raised to $12 from $8 at H.C. Wainwright
6M ago
IMMX
Immix Biopharma Enters Underwriting Agreement with Morgan Stanley
PremiumCompany Announcements
Immix Biopharma Enters Underwriting Agreement with Morgan Stanley
6M ago
8K
IMMX
Immix Biopharma Announces Positive Phase 2 Trial Results
PremiumCompany Announcements
Immix Biopharma Announces Positive Phase 2 Trial Results
6M ago
8K
IMMX
Immix Biopharma 19.12M share Spot Secondary priced at $5.10
PremiumThe FlyImmix Biopharma 19.12M share Spot Secondary priced at $5.10
6M ago
IMMX
Immix Biopharma announces phase 2 NXC-201 results
Premium
The Fly
Immix Biopharma announces phase 2 NXC-201 results
6M ago
IMMX
Immix Biopharma Updates Accounting Firm Consents
Premium
Company Announcements
Immix Biopharma Updates Accounting Firm Consents
6M ago
8K
IMMX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >